CTKB

Cytek Biosciences, Inc. Health Care Laboratory Analytical Instruments Russell 3000
$6.13Close $788.0MMarket cap $3.36 – $6.3052-week range Nov 4, 2026Next report · after the close

Highlights

Strengths

  • In a stage-2 uptrend all 8 trend conditions pass
  • Leading the market RS 90 · stronger than 90% of stocks over 12 months
  • Near its high 3% below its 52-week high
  • Accumulation up-day volume 2.3× down-day volume over 50 sessions

Cautions

  • Results soon Nov 4, 2026, in 3 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 5, 2026
Off 12-month high 3%
1wk up 9.7% price change
1mo up 2.9% price change
12-month return up 60% market up 11% · its own up 42%
F-score 3 / 9 Weak
Altman Z 4.60 Low risk
P/E — price / earnings
PEG — P/E / EPS growth
P/B 2.3× price / book
Earnings yield down 5.8% EBIT / enterprise value
Cheaper than 32% of the market · expensive
Revenue growth up 1% year on year
EPS growth — latest quarter
Sales growth up 6% latest quarter · -1 pts
ROE down 18% return on equity
Free cash margin down 4% -$8.8M FCF
D/E 0.00 long-term debt / equity
Net debt / EBITDA —
Interest cover —EBIT / interest
Piotroski tests
  • not yet profitable on its assets
  • operating cash flow is negative
  • profitability slipped from last year
  • short-term liquidity weakened
  • gross margin narrowed
  • assets working less efficiently
  • profits backed by cash
  • reduced long-term debt
  • no new shares issued

Repair signals

  • Long-term debt down 50% ($0.0B → $0.0B)

Trade setup

ATR% 4.6% $0.28 a day · 2×ATR $5.57
RS 90 / 99 vs the universe
Trend 8 / 8 trend template
Relative volume 1.5× vs 50-day average
Up/down volume 2.29 50 sessions
Implied move — no option chain · report Nov 4, 2026
Trend template · 8 of 8

Screen verdict

Did not qualify for any screen.

Warning signs

1 flagged
  • Gross margin narrowing Gross margin fell from 55.4% to 51.8%. The company is keeping less of each dollar of sales than it did a year ago.
Last reported Aug 5, 2026
Last shock Oct 6, 2026-12% in one session1.9× volumeno filing matched+14% since

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $201.5M +0.5% on FY2024
$0 $250M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $92.8M FY2021 · $128.0M FY2022 · $164.0M FY2023 · $193.0M FY2024 · $200.5M FY2025 · $201.5M
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology -$66.5M
-$100M $0 $20M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $19.4M FY2021 · $3.0M FY2022 · $2.5M FY2023 · -$12.1M FY2024 · -$6.0M FY2025 · -$66.5M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology -$8.8M down to a loss
-$25M $0 $25M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $13.6M FY2021 · $266,000 FY2022 · -$22.0M FY2023 · $633,000 FY2024 · $21.9M FY2025 · -$8.8M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 52%
  • Net -33%
  • Free cash -4%
-50% 0% 100% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 56% · Net 21% · Free cash 15% FY2021 · Gross 62% · Net 2% · Free cash 0% FY2022 · Gross 62% · Net 2% · Free cash -13% FY2023 · Gross 57% · Net -6% · Free cash 0% FY2024 · Gross 55% · Net -3% · Free cash 11% FY2025 · Gross 52% · Net -33% · Free cash -4%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $90.3M net cash
  • Cash
  • Long-term debt
$0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $165.2M FY2021 · Cash $364.6M · Long-term debt $0 FY2022 · Cash $296.6M · Long-term debt $2.3M FY2023 · Cash $167.3M · Long-term debt $1.6M FY2024 · Cash $98.7M · Long-term debt $1.1M FY2025 · Cash $90.9M · Long-term debt $525,000
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 128.55m +311.5% since FY2020
135.37m 31.24m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 31.24m FY2021 · 133.75m FY2022 · 135.37m FY2023 · 130.71m FY2024 · 129.21m FY2025 · 128.55m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $92.8M $128.0M $164.0M $193.0M $200.5M $201.5M
Gross margin 56% 62% 62% 57% 55% 52%
Operating income $13.7M $9.2M -$1.8M -$27.8M -$20.5M -$40.4M
Net income $19.4M $3.0M $2.5M -$12.1M -$6.0M -$66.5M
Net margin 21% 2% 2% -6% -3% -33%
Earnings per share $0.60 $0.04 $0.02 -$0.09 -$0.05 -$0.52
Free cash flow $13.6M $266,000 -$22.0M $633,000 $21.9M -$8.8M
Free cash margin 15% 0% -13% 0% 11% -4%
Cash $165.2M $364.6M $296.6M $167.3M $98.7M $90.9M
Long-term debt — $0 $2.3M $1.6M $1.1M $525,000
Shareholders' equity -$16.0M $405.4M $425.5M $393.1M $395.7M $341.7M
Shares outstanding 31.24m 133.75m 135.37m 130.71m 129.21m 128.55m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 5, 2026 Quarterly ↗ Jun 30, 2026 36d
May 7, 2026 Quarterly ↗ Mar 31, 2026 37d
Feb 26, 2026 Annual ↗ Dec 31, 2025 57d
Nov 5, 2025 Quarterly ↗ Sep 30, 2025 36d
Aug 6, 2025 Quarterly ↗ Jun 30, 2025 37d
May 8, 2025 Quarterly ↗ Mar 31, 2025 38d
Feb 28, 2025 Annual ↗ Dec 31, 2024 59d
Nov 7, 2024 Quarterly ↗ Sep 30, 2024 38d
Aug 6, 2024 Quarterly ↗ Jun 30, 2024 37d
May 8, 2024 Quarterly ↗ Mar 31, 2024 38d
Mar 13, 2024 Annual ↗ Dec 31, 2023 73d
Nov 14, 2023 Quarterly ↗ Sep 30, 2023 45d

Current reports

FiledDisclosed
Sep 29, 2026 Charter or bylaws ↗
Aug 24, 2026 Regulation FD · Other events ↗
Aug 5, 2026 Results ↗
Jul 15, 2026 Director or officer change ↗
Jun 25, 2026 Director or officer change ↗
Jun 16, 2026 Shareholder vote ↗
Jun 2, 2026 Director or officer change ↗
May 7, 2026 Results ↗
Feb 26, 2026 Results ↗
Jan 13, 2026 Results ↗
Nov 5, 2025 Results ↗
Aug 6, 2025 Results ↗